Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBX7 | O95931 | 3/20 | 0.42 |
| ▸ | CDYL2 | Q8N8U2 | 3/20 | 0.42 |
| ▸ | CDYL | Q9Y232 | 3/20 | 0.42 |
| ▸ | CDY1; CDY1B | Q9Y6F8 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TSPO | P30536 | 1/20 | 0.41 |
| ▸ | KMO | O15229 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CD74 | P04233 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22314460 | 0.93 | ALDH1A1 (0.43) | CBX7CDYL2CDYLCDY1; CDY1BALDH1A1 | |
| SCHEMBL25865007 | 0.87 | TSPO (0.39) | CBX7CDYL2CDYLCDY1; CDY1BALDH1A1 | |
| SCHEMBL25865003 | 0.85 | TSPO (0.47) | ALDH1A1TSPOKMO | |
| SCHEMBL22314463 | 0.80 | CYP1A2 (0.39) | CBX7CDYL2CDYLCDY1; CDY1BALDH1A1 | |
| SCHEMBL25867976 | 0.80 | TSPO (0.38) | CBX7CDYL2CDYLCDY1; CDY1BALDH1A1 | |
| SCHEMBL22314496 | 0.76 | TSPO (0.43) | ALDH1A1TSPO | |
| SCHEMBL25865038 | 0.74 | TNIK (0.39) | ALDH1A1CHRM5MAPT | |
| SCHEMBL22314889 | 0.74 | TSPO (0.46) | ALDH1A1TSPOKMO | |
| SCHEMBL26004871 | 0.73 | TDO2 (0.42) | CHRM5 | |
| SCHEMBL22314464 | 0.72 | ALDH1A1 (0.50) | ALDH1A1TSPOKMOSMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219938-A1 | COMPOUNDS AND THEIR METHODS OF USE | PRAXIS PREC MEDICINES INC (US) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219938-A1 | COMPOUNDS AND THEIR METHODS OF USE | SCN1A, SCN3A, SCN1B | CBX7 1133/4885CDYL2 1702/4885CDYL 2252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.